School of Medicine
Showing 201-244 of 244 Results
-
Michelle Arteaga, MS, MHA
Global Engagement Programs Manager, Anesthesia
Current Role at StanfordGlobal Engagement Programs Manager
-
Robin Augustine
Basic Life Research Scientist, Rad/Pediatric Radiology
Current Role at StanfordDr. Robin Augustine's current research interests center on three captivating areas: graphene-based bioscaffolds, islet transplantation, and synchronized cellular response. In the realm of graphene-based bioscaffolds, Dr. Augustine actively explores graphene's potential as a biomaterial for tissue engineering. With its unique properties, graphene offers exceptional opportunities for developing innovative bioscaffolds. Dr. Augustine aims to design and engineer graphene-based materials that can provide structural support, promote cellular adhesion and growth, and enhance tissue regeneration. Leveraging the exceptional properties of graphene, such as its mechanical strength, electrical conductivity, and biocompatibility, Dr. Augustine's goal is to contribute to the development of advanced bioscaffolds for various applications in regenerative medicine. Another area of Dr. Augustine's research focuses on islet transplantation, particularly in treating diabetes. Islet transplantation holds promise as a potential cure for type 1 diabetes, involving the transfer of insulin-producing islet cells into the recipient's pancreas. Dr. Augustine investigates strategies to optimize islet transplantation techniques, improve the long-term viability of transplanted islets, and enhance their functionality. The ultimate objective is to contribute to the development of more effective and sustainable approaches for islet transplantation, with the aim of improving the quality of life for individuals living with diabetes. Dr. Augustine also explores the field of synchronized cellular response, recognizing its crucial role in tissue development, regeneration, and repair. The focus is on understanding and manipulating synchronized cellular response in complex tissue systems. By studying the intricate signaling pathways and cellular interactions, Dr. Augustine aims to identify key factors and mechanisms that regulate coordinated cellular behavior. This knowledge can inform the development of strategies to enhance tissue regeneration and repair processes, potentially leading to improved outcomes in various biomedical applications. Through research in graphene-based bioscaffolds, islet transplantation, and synchronized cellular response, Dr. Augustine strives to contribute to the advancement of tissue engineering, regenerative medicine, and the development of innovative therapies for complex medical challenges.
-
Mukta Awasthi
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
BioI have been an academic hospitalist for over twenty years, and currently work at the Veterans Affairs Medical Center in Palo Alto where I serve as teaching faculty for Stanford medicine residents and students. I am currently Medical Director of the Intermediate Intensive Care Unit (IICU). I am passionate about delivering quality medical care and my interests include Process Improvement , Narrative Medicine, Medical Education.
-
Mary Ayers
Director of Learning Spaces and Immersive Learning Center Operations, Immersive and Simulation-based Learning
Current Role at StanfordAs Director of Operations for Learning Spaces and the Immersive Learning Center, Mary oversees the learning space and resource scheduling services and facilities support teams in the School of Medicine to ensure outstanding services to faculty and staff.
-
Farzad Azimpour
Casual - Non-Exempt, School of Medicine - MDRP'S - Biodesign Program
BioFarzad leads Edwards Lifesciences' strategic innovation and future technologies incubator in the Advanced Technology unit as Senior Vice President. He is a cardiologist and medtech designer by background, bringing academic, start-up, and strategic industry experience applying needs-driven innovation discipline to solve high-impact challenges in cardiovascular disease.
Within his role, Farzad heads the Edwards Lifesciences Innovation Fellowship Program for cardiovascular physicians and surgeons, in partnership with the Cardiovascular Research Foundation (CRF).
Academically, Farzad serves as Associate Director, Lead for Design at Stanford University's Byers Center for Biodesign where he teaches the application of design thinking to lifesciences.
He previously served as Director of Health at the global design and innovation firm IDEO, and Chief Medical Officer at Myia Labs, an American College of Cardiology and venture capital-backed digital health start-up.
Farzad completed his training in medicine and cardiology at the Cleveland Clinic and the University of Minnesota / Lillehei Heart Institute respectively, served as Chief Cardiology Fellow and NIH T32 Research Fellow designing and testing advanced cardiovascular technologies, and operated as the St. Jude Medical and Dean's Innovation Fellow at Stanford Biodesign.
He holds patents and patents pending in the fields of interventional cardiology, cardiac electrophysiology, and robotic surgery.
Farzad earned both his bachelor's degree in biological sciences and his MD from the University of Texas at Austin, and his post-doc in Biodesign from Stanford University School of Medicine.
He is a recipient of Phi Beta Kappa distinction and the Arnold P. Gold Humanism in Medicine Award.
